Skip to content

Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage

Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05246969
Enrollment
58
Registered
2022-02-18
Start date
2017-06-01
Completion date
2022-02-01
Last updated
2022-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Sepsis Bacterial, Sepsis, Severe, Sepsis Syndrome, Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal

Keywords

sequential organ failure assessment score

Brief summary

The study aims to evaluate the suitability of the SOFA score implemented by the Sepsis 3 guideline to detect sepsis in patients suffering from subrarachnoid hemorrhage.

Interventions

OTHERSepsis detection

The aim of the study was to observe whether the treating physicians were able to detect sepsis by strictly applying the recommended SOFA score.

Sponsors

Goethe University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Critically ill patients suffering from moderate to severe subarachnoid hemorrhage (WFNS \>2).

Exclusion criteria

children under the age of 18 years Patients with minor subarachnoid hemorrhage \< WFNS stage 2.

Design outcomes

Primary

MeasureTime frameDescription
Sepsis SOFA positiveup to 2 monthsSepsis correctly detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)
Sepsis SOFA negativeup to 2 monthsSepsis not detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026